Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Clinical trial NCT04141150 · UNKNOWN

Trial details

NCT number: NCT04141150
Sponsor: APRINOIA Therapeutics, LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease Mild Cognitive Impairment Due to Alzheimer's Disease Healthy Volunteers

Start date: 2022-03-22
Primary completion: 2024-09-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.